financetom
Business
financetom
/
Business
/
Wendy's Lowers Fiscal 2025 Outlook Despite Second-Quarter Beat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wendy's Lowers Fiscal 2025 Outlook Despite Second-Quarter Beat
Aug 8, 2025 7:58 AM

10:26 AM EDT, 08/08/2025 (MT Newswires) -- Wendy's (WEN) lowered its full-year earnings and global systemwide sales outlook on Friday, even though the fast food chain recorded fiscal second-quarter results above market expectations.

The company now anticipates adjusted earnings to come in between $0.82 and $0.89 per share for fiscal 2025, down from its previous projections of $0.92 to $0.98. The current consensus on FactSet is for non-GAAP EPS of $0.94.

Global systemwide sales are forecast to decline by 3% to 5% for the ongoing fiscal year, compared with the company's prior outlook range of flat to down 2%. Wendy's reiterated its global net unit growth guidance of 2% to 3% for the year.

"Based on our US business's second quarter performance, what we have seen so far in the third quarter and the shift of certain programming initiatives from 2025 into 2026, we have updated our outlook for the full year 2025," Chief Accounting Officer Suzie Thuerk said during an earnings call, according to a FactSet transcript. "Accordingly, our updated outlook assumes the dynamic consumer behavior and challenging competitive environment persists throughout the remainder of the year."

For the second quarter, adjusted EPS rose to $0.29 from $0.27, defying the Street's view for a decline to $0.25. Revenue decreased 1.7% to $560.9 million, but surpassed the average analyst estimate of $558 million. The stock was up 1.8% in Friday trade.

Same-restaurant sales around the world were down 2.9% in the quarter, more than the 2.2% decline modeled by the market. In the US, the metric fell 3.6% versus a 0.6% gain in the prior-year quarter. International same-restaurant sales growth decelerated to 1.8% from 2.5% last year.

"In the US, we have work to do to improve the overall performance of the business," interim Chief Executive Ken Cook said in the earnings release. "We will continue to strengthen relationships with franchisees, improve the effectiveness of our marketing programs, and elevate the customer experience across the system."

Systemwide sales slipped 1.8% on an annual basis in the second quarter. The company added 26 net new restaurants during the period.

Price: 10.26, Change: +0.30, Percent Change: +2.96

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chart Industries, Element Resources to Support Hydrogen Eco-System Deployment
Chart Industries, Element Resources to Support Hydrogen Eco-System Deployment
Aug 29, 2024
09:40 AM EDT, 08/29/2024 (MT Newswires) -- Chart Industries ( GTLS ) said Thursday it is collaborating with Element Resources to support the adoption of hydrogen and other clean fuels through an eco-system approach. The collaboration focuses on developing hydrogen fuel supply, distribution, storage, and transportation systems, the company said. Chart Industries ( GTLS ) shares were up 2.2% in...
What's Going On With Lingerie Giant Victoria's Secret Stock Today?
What's Going On With Lingerie Giant Victoria's Secret Stock Today?
Aug 29, 2024
Victoria’s Secret & Co. shares are trading lower after the company reported second-quarter results yesterday. Revenue fell 1% Y/Y to $1.417 billion, beating the consensus of $1.41 billion. Total comparable sales for the quarter decreased 3%. Adjusted operating income stood at $62 million vs. $49 million a year ago.  Adjusted EPS of $0.40 beat the consensus of $0.36, slightly above the recently reported preliminary adjusted EPS of $0.34 – $0.39....
Adaptive Biotechnologies Receives IVDR Certification for clonoSEQ
Adaptive Biotechnologies Receives IVDR Certification for clonoSEQ
Aug 29, 2024
09:40 AM EDT, 08/29/2024 (MT Newswires) -- Adaptive Biotechnologies ( ADPT ) said Thursday that its clonoSEQ minimal residual disease test in lymphoid malignancies has received In Vitro Diagnostics Regulation class C certification in the European Union. Under IVDR, the test is intended to detect minimal residual disease in patients with B-cell malignancies during and after treatment, the company said....
ONEOK Spends $3B On EnLink Midstream Stake, $2.6B On Medallion
ONEOK Spends $3B On EnLink Midstream Stake, $2.6B On Medallion
Aug 29, 2024
EnLink Midstream ( ENLC ) shares are trading higher premarket Thursday after ONEOK, Inc. ( OKE ) agreed to acquire Global Infrastructure Partners‘ (GIP) 43% stake in the company for $3 billion, or $14.90 per unit. The per unit price represents a 12.8% premium over EnLink’s closing market price as of Aug. 27, 2024. The deal also includes 100% of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved